Mipasetamab, an IgG1kappa antibody, targets AXL, a tyrosine kinase receptor and TAM Receptor. It plays a crucial role in synthesizing ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC), known for its anti-tumor activity [1].
CAS Number:
[2361055-48-1]
* VAT and and shipping costs not included. Errors and price changes excepted